Skip to content

Clinical trials

Phase 3 Gliosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gliosarcoma Phase: Phase 3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20061
20071
20081
20091
20111
20151
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radiation Therapy Oncology Group2
Wake Forest University Health Sciences2
AbbVie1
Case Comprehensive Cancer Center1
Celldex Therapeutics1
Colorado Health Foundation1
INSYS Therapeutics Inc1
NRG Oncology1
National Cancer Institute (NCI)1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma13
Gliosarcoma13
Brain Neoplasms8
Central Nervous System Neoplasms6
Astrocytoma5
Glioma4
Ependymoma3
Glioma, Subependymal3
Meningioma3
Neuroectodermal Tumors, Primitive3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.